341 related articles for article (PubMed ID: 30716477)
1. No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.
Dong J; Gharahkhani P; Chow WH; Gammon MD; Liu G; Caldas C; Wu AH; Ye W; Onstad L; Anderson LA; Bernstein L; Pharoah PD; Risch HA; Corley DA; Fitzgerald RC; ; Iyer PG; Reid BJ; Lagergren J; Shaheen NJ; Vaughan TL; MacGregor S; Love S; Palles C; Tomlinson I; Gockel I; May A; Gerges C; Anders M; Böhmer AC; Becker J; Kreuser N; Thieme R; Noder T; Venerito M; Veits L; Schmidt T; Schmidt C; Izbicki JR; Hölscher AH; Lang H; Lorenz D; Schumacher B; Mayershofer R; Vashist Y; Ott K; Vieth M; Weismüller J; Nöthen MM; Moebus S; Knapp M; Peters WHM; Neuhaus H; Rösch T; Ell C; Jankowski J; Schumacher J; Neale RE; Whiteman DC; Thrift AP
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2227-2235.e1. PubMed ID: 30716477
[TBL] [Abstract][Full Text] [Related]
2. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
[TBL] [Abstract][Full Text] [Related]
3. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study.
Thrift AP; Shaheen NJ; Gammon MD; Bernstein L; Reid BJ; Onstad L; Risch HA; Liu G; Bird NC; Wu AH; Corley DA; Romero Y; Chanock SJ; Chow WH; Casson AG; Levine DM; Zhang R; Ek WE; MacGregor S; Ye W; Hardie LJ; Vaughan TL; Whiteman DC
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269698
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
[TBL] [Abstract][Full Text] [Related]
5. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization.
Thrift AP; Risch HA; Onstad L; Shaheen NJ; Casson AG; Bernstein L; Corley DA; Levine DM; Chow WH; Reid BJ; Romero Y; Hardie LJ; Liu G; Wu AH; Bird NC; Gammon MD; Ye W; Whiteman DC; Vaughan TL
Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1667-76.e1. PubMed ID: 24530603
[TBL] [Abstract][Full Text] [Related]
6. Serum 25-Hydroxyvitamin D Levels and the Risk of Dysplasia and Esophageal Adenocarcinoma in Patients with Barrett's Esophagus.
Thota PN; Kistangari G; Singh P; Cummings L; Hajifathalian K; Lopez R; Sanaka MR
Dig Dis Sci; 2016 Jan; 61(1):247-54. PubMed ID: 26233550
[TBL] [Abstract][Full Text] [Related]
7. Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
Xie SH; Fang R; Huang M; Dai J; Thrift AP; Anderson LA; Chow WH; Bernstein L; Gammon MD; Risch HA; Shaheen NJ; Reid BJ; Wu AH; Iyer PG; Liu G; Corley DA; Whiteman DC; Caldas C; Pharoah PD; Hardie LJ; Fitzgerald RC; Shen H; Vaughan TL; Lagergren J
Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2701-2709.e3. PubMed ID: 31756444
[TBL] [Abstract][Full Text] [Related]
8. Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
Dighe SG; Chen J; Yan L; He Q; Gharahkhani P; Onstad L; Levine DM; Palles C; Ye W; Gammon MD; Iyer PG; Anderson LA; Liu G; Wu AH; Dai JY; Chow WH; Risch HA; Lagergren J; Shaheen NJ; Bernstein L; Corley DA; Prenen H; deCaestecker J; MacDonald D; Moayyedi P; Barr H; Love SB; Chegwidden L; Attwood S; Watson P; Harrison R; Ott K; Moebus S; Venerito M; Lang H; Mayershofer R; Knapp M; Veits L; Gerges C; Weismüller J; Gockel I; Vashist Y; Nöthen MM; Izbicki JR; Manner H; Neuhaus H; Rösch T; Böhmer AC; Hölscher AH; Anders M; Pech O; Schumacher B; Schmidt C; Schmidt T; Noder T; Lorenz D; Vieth M; May A; Hess T; Kreuser N; Becker J; Ell C; Ambrosone CB; Moysich KB; MacGregor S; Tomlinson I; Whiteman DC; Jankowski J; Schumacher J; Vaughan TL; Madeleine MM; Hardie LJ; Buas MF
Carcinogenesis; 2021 Apr; 42(3):369-377. PubMed ID: 33300568
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
Ek WE; Lagergren K; Cook M; Wu AH; Abnet CC; Levine D; Chow WH; Bernstein L; Risch HA; Shaheen NJ; Bird NC; Corley DA; Hardie LJ; Fitzgerald RC; Gammon MD; Romero Y; Liu G; Ye W; Vaughan TL; MacGregor S; Whiteman DC; Westberg L; Lagergren J
Int J Cancer; 2016 Mar; 138(5):1146-52. PubMed ID: 26414697
[TBL] [Abstract][Full Text] [Related]
10. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
[TBL] [Abstract][Full Text] [Related]
11. Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.
Bull LM; White DL; Bray M; Nurgalieva Z; El-Serag HB
Dis Esophagus; 2009; 22(7):571-87. PubMed ID: 19222528
[TBL] [Abstract][Full Text] [Related]
12. A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma.
Murphy SJ; Hughes AE; Patterson CC; Anderson LA; Watson RG; Johnston BT; Comber H; McGuigan J; Reynolds JV; Murray LJ
Carcinogenesis; 2007 Jun; 28(6):1323-8. PubMed ID: 17277236
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
[TBL] [Abstract][Full Text] [Related]
14. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.
Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.
Gharahkhani P; Fitzgerald RC; Vaughan TL; Palles C; Gockel I; Tomlinson I; Buas MF; May A; Gerges C; Anders M; Becker J; Kreuser N; Noder T; Venerito M; Veits L; Schmidt T; Manner H; Schmidt C; Hess T; Böhmer AC; Izbicki JR; Hölscher AH; Lang H; Lorenz D; Schumacher B; Hackelsberger A; Mayershofer R; Pech O; Vashist Y; Ott K; Vieth M; Weismüller J; Nöthen MM; ; ; ; Attwood S; Barr H; Chegwidden L; de Caestecker J; Harrison R; Love SB; MacDonald D; Moayyedi P; Prenen H; Watson RGP; Iyer PG; Anderson LA; Bernstein L; Chow WH; Hardie LJ; Lagergren J; Liu G; Risch HA; Wu AH; Ye W; Bird NC; Shaheen NJ; Gammon MD; Corley DA; Caldas C; Moebus S; Knapp M; Peters WHM; Neuhaus H; Rösch T; Ell C; MacGregor S; Pharoah P; Whiteman DC; Jankowski J; Schumacher J
Lancet Oncol; 2016 Oct; 17(10):1363-1373. PubMed ID: 27527254
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Impact of Antireflux Treatment on Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus: Insights from a Mendelian Randomization Study.
Li Z; Yang K
Gastroenterology; 2024 May; 166(5):944-945. PubMed ID: 38246505
[No Abstract] [Full Text] [Related]
17. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
Akagi T; Ito T; Kato M; Jin Z; Cheng Y; Kan T; Yamamoto G; Olaru A; Kawamata N; Boult J; Soukiasian HJ; Miller CW; Ogawa S; Meltzer SJ; Koeffler HP
Int J Cancer; 2009 Nov; 125(10):2349-59. PubMed ID: 19670330
[TBL] [Abstract][Full Text] [Related]
19. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
Dong J; Levine DM; Buas MF; Zhang R; Onstad L; Fitzgerald RC; ; Corley DA; Shaheen NJ; Lagergren J; Hardie LJ; Reid BJ; Iyer PG; Risch HA; Caldas C; Caldas I; Pharoah PD; Liu G; Gammon MD; Chow WH; Bernstein L; Bird NC; Ye W; Wu AH; Anderson LA; MacGregor S; Whiteman DC; Vaughan TL; Thrift AP
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1598-1606.e4. PubMed ID: 29551738
[TBL] [Abstract][Full Text] [Related]
20. Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing.
Maag JLV; Fisher OM; Levert-Mignon A; Kaczorowski DC; Thomas ML; Hussey DJ; Watson DI; Wettstein A; Bobryshev YV; Edwards M; Dinger ME; Lord RV
Mol Cancer Res; 2017 Nov; 15(11):1558-1569. PubMed ID: 28751461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
